TY - JOUR
T1 - Clinical Pharmacokinetic Significance of the Renal Tubular Secretion of Digoxin
AU - Koren, Gideon
PY - 1987/11
Y1 - 1987/11
N2 - Tubular secretion appears to be a major route of the renal elimination of digoxin. Secretion of the drug by the tubules is modulated by renal blood flow, by a number of commonly coadministered drugs (e.g. quinidine, spironolactone, verapamil, amiodarone), and by age. The maximal transport capacity does not appear to be achieved with clinically relevant concentrations. The tubular transport of digoxin does not appear to be associated with the anionic or cationic transport systems, nor the Na+/K+-ATPase receptor. Further studies are needed to elucidate the exact mechanisms involved in the transtubular movement of the glycoside.
AB - Tubular secretion appears to be a major route of the renal elimination of digoxin. Secretion of the drug by the tubules is modulated by renal blood flow, by a number of commonly coadministered drugs (e.g. quinidine, spironolactone, verapamil, amiodarone), and by age. The maximal transport capacity does not appear to be achieved with clinically relevant concentrations. The tubular transport of digoxin does not appear to be associated with the anionic or cationic transport systems, nor the Na+/K+-ATPase receptor. Further studies are needed to elucidate the exact mechanisms involved in the transtubular movement of the glycoside.
UR - http://www.scopus.com/inward/record.url?scp=0023630513&partnerID=8YFLogxK
U2 - 10.2165/00003088-198713050-00004
DO - 10.2165/00003088-198713050-00004
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 3319348
AN - SCOPUS:0023630513
SN - 0312-5963
VL - 13
SP - 334
EP - 343
JO - Clinical Pharmacokinetics
JF - Clinical Pharmacokinetics
IS - 5
ER -